ARDELYX, INC. Proceeds from Sale of Other Investments
ARDELYX, INC. (ARDX) reported Proceeds from Sale of Other Investments of $1.00 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfOtherInvestments · last filed 2019-11-06
- ARDELYX, INC. proceeds from sale of other investments for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- ARDELYX, INC. proceeds from sale of other investments for the quarter ending 2018-06-30 was $0.00.
- ARDELYX, INC. proceeds from sale of other investments for the quarter ending 2018-03-31 was $850.00K, a 91.89% decline year-over-year.
- ARDELYX, INC. proceeds from sale of other investments for the quarter ending 2017-09-30 was $6.38M.
| Period end | Proceeds from Sale of Other Investments 3 month | Proceeds from Sale of Other Investments 6 month | Proceeds from Sale of Other Investments 9 month |
|---|---|---|---|
| 2019-09-30 | $1.00M 10-Q · filed 2019-11-06 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $850.00K 10-Q · filed 2019-11-06 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $850.00K 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $850.00K 10-Q · filed 2019-05-07 | ||
| 2017-09-30 | $6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $6.38M derived: sum of 2 quarters · filed 2018-11-07 | $16.86M 10-Q · filed 2018-11-07 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $10.48M 10-Q · filed 2018-08-07 | |
| 2017-03-31 | $10.48M 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |